Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

The health landscape sees pivots as companies adjust strategies: Bristol Myers and Pfizer offer discounts on Eliquis, Newcastle University's IVF technique prevents genetic diseases, and Juul's ...

A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.

Find out which vaccines are recommended while you're pregnant to protect you and your baby, and which you'll need to wait on.

The agreement, signed Monday between CMS and DHS, has not been announced publicly, AP reports. Other Trump administration ...

The agreement allows manufacturers to develop, manufacture and supply generic long-acting injectable cabotegravir for treatment in 133 countries.

Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy appeared at risk.

An FDA advisory committee ruled in two separate votes that two belantamab mafodotin combination regimens should not be used ...

Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...